Bruce L. A. Carter, Director at Mirati Therapeutics, Inc. (MRTX), sold 3,000 shares at $72.50 ($221K) on 2019-02-20, disclosed to the SEC on 2019-02-22.
Open-market sale of $221k MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.50 | 900 | $65K | 29.5% |
| 2 | $73.79 | 1,000 | $74K | 33.4% |
| 3 | $74.44 | 1,100 | $82K | 37.1% |
| Total | $73.64 avg | 3,000 | $221K | 100% |
| Filing → |
| MRTX | SELL | 2021-04-06 | $746K | — | Filing → |
| MRTX | SELL | 2021-02-03 | $430K | — | Filing → |
| MRTX | SELL | 2020-12-16 | $1.1M | — | Filing → |